Skip To Main Content
Daniel Muñoz-Barba on Muck Rack

Daniel Muñoz-Barba

As seen in: Wiley Online Library, MDPI, Taylor & Francis Online
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Daniel

Contact Daniel, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Ultrasound features of hidradenitis suppurativa tunnels treated with bimekizumab

|
By Alberto Soto-Moreno, Javier León-Pérez, Daniel Muñoz-Barba
| Wiley Online Library Verified
Soto-Moreno, A., León-Perez, J., Muñoz-Barba, D., Castro-Martín, J., Rodríguez-Sanna, A. and Molina-Leyva, A. (2026), Ultrasound features of hidradenitis suppurativa tunnels treated with bimekizumab. J Eur Acad Dermatol Venereol. https://doi.org/10.1111/jdv.70438 No abstract is available for this article. DATA AVAILABILITY STATEMENT Data supporting the conclusions of this study are available upon request from the corresponding author. REFERENCES 1, , , , .
Open in Who Shared View Duplicates (137) Issue with article?

Effectiveness and safety of Baricitinib in alopecia areata: a prospective cohort study

|
By Daniel Muñoz-Barba, Carmen García-Moronta, Sofía Haselgruber-de Francisco, Manuel Sánchez-Díaz
| Taylor & Francis Online
?Mathematical formulae have been encoded as MathML and are displayed in this HTML version using MathJax in order to improve their display. Uncheck the box to turn MathJax off. This feature requires Javascript. Click on a formula to zoom. Abstract Background and objectives Baricitinib was effective in treating severe alopecia areata (AA) in clinical trials, yet real-world prospective data remain scarce. The aim of this study was to assess real-world effectiveness and safety of Baricitinib.
Open in Who Shared Issue with article?

Severity and Therapeutic Decisions Based on Lesion Location in Patients With Hidradenitis Suppurativa

|
By Daniel Muñoz-Barba, Francisco Javier Leon-Pérez, Carlos Cuenca-Barrales, Salvador Arias-Santiago
| Wiley Online Library Verified
Background Hidradenitis suppurativa (HS) is a chronic inflammatory disease for which several phenotypic classifications have been proposed in recent years to optimize medical care. The aim of this study was to define a new classification of HS based on the anatomical distribution of lesions, serving as a tool for therapeutic decision-making.
Open in Who Shared Issue with article?
See all 5 articles